SCHEMBL661996

SCHEMBL661996

NS(=O)(=O)c1ccc(NC(=O)C2=CN(CC(=O)c3ccccc3)C=CC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 13/20 0.54
CA1 P00915 12/20 0.54
CA9 Q16790 8/20 0.54
CA12 O43570 7/20 0.54
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
PSMD14 O00487 2/20 0.50
POLB P06746 2/20 0.50
MAPT P10636 2/20 0.50
CACNA1B Q00975 2/20 0.50
APBA1 Q02410 2/20 0.50
RECQL P46063 1/20 0.50
CTDSP1 Q9GZU7 1/20 0.50
SAE1 Q9UBE0 1/20 0.50
UBA2 Q9UBT2 1/20 0.50
CA7 P43166 3/20 0.47
PLK1 P53350 1/20 0.46
FGB P02675 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL660154 0.81 SMN1; SMN2 (0.39) CA12KMT2AMEN1MAPTGAA
SCHEMBL298474 0.79 SMN1; SMN2 (0.40) CA12KMT2AMEN1MAPTCTDSP1
SCHEMBL658725 0.78 POLB (0.46) CA2CA1CA9KMT2AMEN1
SCHEMBL660454 0.78 KAT6A (0.51) KMT2AMEN1MAPTGAAALDH1A1
SCHEMBL660917 0.77 ALDH1A1 (0.40) CA12KMT2AMEN1MAPTGAA
SCHEMBL287206 0.77 PTGS2 (0.47) KMT2AMEN1MAPTCYP2C9CYP2C19
SCHEMBL660526 0.76 KAT6A (0.35) KMT2AMEN1MAPTGAAALDH1A1
SCHEMBL298933 0.76 RAB9A (0.40) CA12KMT2AMEN1POLBMAPT
SCHEMBL658510 0.76 POLB (0.47) KMT2AMEN1POLBMAPTNPSR1
SCHEMBL27854995 0.75 ALDH1A1 (0.41) CA12KMT2AMEN1MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS AGER, REN, AGT CA2 3360/4885CA1 4734/4885CA9 3342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.